Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s SpringWorks Therapeutics SWTX Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-282,105	Closed	-$12.4M	–	60
2025 Q1	$12.4M	Buy	+282,105	New	+$13M	2.57%	15

Other funds holding SWTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's SWTX Position: Q2 2025 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 282,105 shares — an estimated $12.4M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in SWTX in Q1 2025 and held it in 1 quarter. The position peaked at $12.4M in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 282,105 SpringWorks Therapeutics shares in Q2 2025, an estimated $12.4M.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 1 quarter.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's SpringWorks Therapeutics position peaked at $12.4M in Q1 2025.
222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q2 2025, filed 25 Jul 2025.